Ceftriaxone and cefotaxime are equally effective in the treatment of neutropenic fever.
Cornely
O A
OA
Klinik für Innere Medizin, Universitätsklinik Köln, Deutschland. Oliver.Cornely@uni-koeln.de
Salzberger
B
B
Bethe
U
U
Seifert
H
H
Fätkenheuer
G
G
Diehl
V
V
Schrappe
M
M
D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D001424:Bacterial Infections / Q000209:etiology / Q000517:prevention & control; D002439:Cefotaxime / Q000008:administration & dosage*; D002443:Ceftriaxone / Q000008:administration & dosage*; D002511:Cephalosporins / Q000008:administration & dosage*; D005334:Fever / Q000188:drug therapy* / Q000209:etiology; D019337:Hematologic Neoplasms / Q000188:drug therapy; D006801:Humans; D007262:Infusions, Intravenous; D008875:Middle Aged; D009503:Neutropenia / Q000188:drug therapy* / Q000209:etiology; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D002511:Cephalosporins; D002443:Ceftriaxone; D002439:Cefotaxime